| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30007938 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30012830 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30007939 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30012831 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30088389 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30052769 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30052770 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30052771 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30052772 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
| TVIS30052773 | HIV | ENSG00000101266.19 | protein_coding | CSNK2A1 | No | No | 1457 | P68400 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CSNK2A1 |
|---|---|
| DrugBank ID | DB00171 |
| Drug Name | ATP |
| Target ID | BE0001209 |
| UniProt ID | P68400 |
| Regulation Type | |
| PubMed IDs | 21174434 |
| Citations | Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, Haddach M, Michaux J, Nagasawa J, Schwaebe MK, Stefan E, Vialettes A, Whitten JP, Chen TK, Darjania L, Stansfield R, Anderes K, Bliesath J, Drygin D, Ho C, Omori M, Proffitt C, Streiner N, Trent K, Rice WG, Ryckman DM: Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J Med Chem. 2011 Jan 27;54(2):635-54. doi: 10.1021/jm101251q. Epub 2010 Dec 21. |
| Groups | Investigational; Nutraceutical |
| Direct Classification | Purine ribonucleoside triphosphates |
| SMILES | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O |
| Pathways | Glycerolipid Metabolism; Fatty Acid Metabolism; Pamidronate Action Pathway; Simvastatin Action Pathway; Citric Acid Cycle; Glutamate Metabolism; Argininosuccinic Aciduria; Gluconeogenesis; Betaine Metabolism; Butyrate Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Rosuvastatin Action Pathway; Propanoate Metabolism; Pentose Phosphate Pathway; Pyruvate Metabolism; Inositol Metabolism; Zoledronate Action Pathway; Glycine and Serine Metabolism; Selenoamino Acid Metabolism; Thiamine Metabolism; Pyrimidine Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Ammonia Recycling; Histidine Metabolism; Pravastatin Action Pathway; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Purine Metabolism; Fluvastatin Action Pathway; Galactose Metabolism |
| PharmGKB | PA164743471 |
| ChEMBL | CHEMBL14249 |
